ESR1 and breast cancer: Findings obtained from a retrospective clinical study revealed strong association of HOTAIR overexpression with risk of metastasis in the estrogen receptor positive (ER+) breast cancer patients who diagnosed with primary tumours and received no adjuvant therapy, suggesting this lincRNA as a potential prognostic biomarker in this type of patients [71].